Clinical Trial

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to assess feasibility, tolerability and preliminary effectiveness of MDMA-assisted therapy for adjustment disorder (AD) in 10 dyads of patients with cancer and a concerned significant other (CSO) (20 participants total). Participants will undergo an 8-week treatment period which will include two doses of MDMA, two Preparatory Sessions and four Integrative Sessions of non-drug therapy.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-10-13; most recent amendment 2026-04-28.
Trial Details
NCT Number NCT05584826
Lead Sponsor Sunstone Medical
Conditions Cancer, Adjustment Disorders
Enrollment 20 participants
Start Date 2022-10-06
Primary Completion 2026-10 (estimated)
Study Completion 2028-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-04